Toby Maher, MD, PhD, professor of clinical medicine, Keck Medicine of USC, discusses the impact of changes in lung function in patients with idiopathic pulmonary fibrosis (IPF). How does the rate of ...
A pair of studies presented at the European Respiratory Society Congress 2024 emphasized the importance of close monitoring and proactive treatment approaches for patients with idiopathic (IPF) and ...
Dose-ranging trial evaluated deupirfenidone 550 mg three times a day (TID) (approximately equivalent exposure to pirfenidone 801 mg TID 1) and deupirfenidone 825 mg TID and successfully demonstrated ...
Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Following use of race-neutral lung function equations, African American and Latino pediatric ...
In a recent study published in The Lancet Digital Health, a group of researchers estimated forced vital capacity (FVC) (Total air exhaled after the deepest breath) and forced expiratory volume in 1 ...
Bexotegrast-treated patients demonstrated improvements in forced vital capacity (FVC) and reduced cough severity compared to placebo. Bexotegrast was well tolerated at 160 mg over 12 weeks of ...
Having low lung function as a middle-aged smoker without airway obstruction raised the likelihood for all-cause mortality, ...
Race-neutral equations for assessing lung function appeared to catch more true-abnormal findings for Black patients than did previously standard race-adjusted spirometry equations, a study showed.
Background Pulmonary function testing provides important insight regarding health; the vital capacity (VC) is so named because of its association with survival and longevity. Interpretation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback